TRC FINECHEM PVT LTD
A dynamic consortium founded in 2017 started at Nashik site having a significant presence in the realm of manufacturing API, Intermediates, Specialty Chemicals, Coupling Reagents & CDMO Business. Our commitment to excellence and innovation is reflected in our state-of-the-art plants strategically located in Maharashtra, R&D in Koparkhairane, Navi Mumbai and plants in Nashik and Dhule (upcoming) each specializing in distinct Product developement and commercial manufacturing.
Our Laboratory
WHO compliant Site, Dhule
Upcoming Dhule Manufacturing Unit – TRC FINECHEM PVT. LTD.
TRC Finechem Pvt. Ltd. is expanding its manufacturing footprint with a state-of-the-art facility in Dhule, Maharashtra, dedicated to the production of Active Pharmaceutical Ingredients (APIs) and Intermediates.
The Dhule unit is being developed to support R&D-to-commercial scale-up, enabling smooth technology transfer from our Navi Mumbai R&D Centre.
The facility is designed with GMP-compliant infrastructure to meet both domestic and international regulatory standards.
It will focus on innovation-driven manufacturing, supporting cost-optimized, eco-friendly, and non-infringing routes for various APIs and intermediates.
The unit will cater to diversified therapeutic segments including ophthalmology, gastroenterology, cardiovascular, CNS, anti-allergic, cosmetics, and perfumery.
Equipped with multi-scale production capabilities, the plant will handle processes from gram to multi-ton scale.
The setup includes specialized systems for handling corrosive, flammable, and toxic chemicals, ensuring maximum safety and compliance.
Dedicated sections will support custom synthesis, contract manufacturing, process optimization, and scale-up studies.
The Dhule facility will feature advanced process chemistry capabilities such as aldol condensation, Grignard synthesis, halogenation, esterification, and coupling reactions.
Infrastructure is planned for gas, liquid, and solid phase handling, with provisions for pressure and multistep reactions.
The plant will enable TRC Finechem to strengthen its CDMO and global supply capabilities, serving healthcare innovators across India and abroad.
With this strategic expansion, TRC Finechem reinforces its commitment to quality, innovation, and sustainable growth in the pharmaceutical sector.
GMP Site, Nashik
Nashik Manufacturing Unit – TRC FINECHEM PVT. LTD.
The Nashik manufacturing facility of TRC Finechem Pvt. Ltd. is a GMP-compliant plant dedicated to the production and development of niche molecules, APIs, and intermediates.
This site plays a pivotal role in TRC’s innovation journey, focusing on complex chemistry and specialty products that demand high precision and expertise.
The Nashik unit is equipped to manage multi-step synthesis and critical reactions, ensuring quality and consistency at every scale of operation.
A key strength of this facility is its capability to perform Hydrogenation reactions under controlled and safe operating conditions.
The site supports process development, scale-up, and commercial manufacturing for products developed at our R&D center in Navi Mumbai.
The facility’s infrastructure enables custom synthesis, route scouting, and process optimization for both domestic and export markets.
Nashik operations emphasize non-infringing process development, adhering to ICH and global regulatory standards.
The site features flexible manufacturing lines capable of producing from gram to multi-ton scale, catering to both pilot and commercial requirements.
Core competencies include eco-friendly chemistry, cost-optimized processes, and chiral molecule development.
Through its niche manufacturing focus, the Nashik site contributes significantly to TRC Finechem’s portfolio of specialized intermediates and APIs.
This facility underscores TRC’s mission to deliver quality, innovation, and value-driven chemical solutions to healthcare and life sciences industries worldwide.